Filing
Spy
Filing
Spy
Home
About
MRK
Merck & Co., Inc.
Global research-intensive biopharmaceutical company
CUSIP: 589331107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q3
6 of 35 quarters
Total Value
$66.59B
Total Shares
802.8K
Net Share Change
-122.2K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Kahn Brothers Group
$66.59B
802.8K
12.6%
TRIM
-122.2K
(-13.2%)
Kahn Brothers Group
$66.59B
802.8K shares
TRIM
-122.2K
(-13.2%)
MRK — Merck & Co., Inc. - FilingSpy